Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial-Reference-Cited by-同舟云学术

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial

Published:2017-01 Issue: Volume:70 Page:133-142
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Rouzier Roman,Gouy Sébastien,Selle Frédéric,Lambaudie Eric,Floquet Anne,Fourchotte Virginie,Pomel Christophe,Colombo Pierre-Emmanuel,Kalbacher Elsa,Martin-Francoise Sandrine,Fauvet Raffaele,Follana Philippe,Lesoin Anne,Lecuru Fabrice,Ghazi Youssef,Dupin Julien,Chereau Elisabeth,Zohar Sarah,Cottu Paul,Joly Florence

Funder

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. Epithelial ovarian cancer;Morgan;J Natl Compr Canc Netw,2011

2. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl J Med,2010

3. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015

4. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N Engl J Med,2011

5. A phase 3 trial of bevacizumab in ovarian cancer;Perren;N Engl J Med,2011

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological Outcomes in Patients with Delayed Cytoreductive Surgery During COVID Times;Indian Journal of Surgical Oncology;2024-09-03

2. Tubal Cancer Clinical Management: Two Exceptional Scenarios and a Review of the Literature;Journal of Clinical Medicine;2024-08-27

3. Optimizing Outcomes: Bevacizumab with Carboplatin and Paclitaxel in 5110 Ovarian Cancer Patients—A Systematic Review and Meta-Analysis;Pharmaceuticals;2024-08-21

4. Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial;Nature Communications;2024-07-16

5. New windows of surgical opportunity for gynecological cancers in the era of targeted therapies;International Journal of Gynecologic Cancer;2024-03